These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 25678783)

  • 1. Detection of acute deterioration in health status visit among COPD patients by monitoring COPD assessment test score.
    Pothirat C; Chaiwong W; Limsukon A; Deesomchok A; Liwsrisakun C; Bumroongkit C; Theerakittikul T; Phetsuk N
    Int J Chron Obstruct Pulmon Dis; 2015; 10():277-82. PubMed ID: 25678783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD.
    Rhee CK; Kim JW; Hwang YI; Lee JH; Jung KS; Lee MG; Yoo KH; Lee SH; Shin KC; Yoon HK
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1623-31. PubMed ID: 26316736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD.
    Miravitlles M; García-Sidro P; Fernández-Nistal A; Buendía MJ; Espinosa de Los Monteros MJ; Esquinas C; Molina J
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2571-9. PubMed ID: 26664105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of COPD Assessment Test and Clinical COPD Questionnaire to predict the risk of exacerbation.
    Jo YS; Yoon HI; Kim DK; Yoo CG; Lee CH
    Int J Chron Obstruct Pulmon Dis; 2018; 13():101-107. PubMed ID: 29317814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COPD assessment test: a simple tool to evaluate disease severity and response to treatment.
    Papaioannou M; Pitsiou G; Manika K; Kontou P; Zarogoulidis P; Sichletidis L; Kioumis IP
    COPD; 2014 Sep; 11(5):489-95. PubMed ID: 24766370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The COPD assessment test and St George's Respiratory Questionnaire: are they equivalent in subjects with COPD?
    Morishita-Katsu M; Nishimura K; Taniguchi H; Kimura T; Kondoh Y; Kataoka K; Ogawa T; Watanabe F; Arizono S; Nishiyama O; Nakayasu K; Imaizumi K; Hasegawa Y
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1543-51. PubMed ID: 27462150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between the COPD Assessment Test score and airflow limitation in Japan in patients aged over 40 years with a smoking history.
    Yoshimoto D; Nakano Y; Onishi K; Hagan G; Jones P
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1357-63. PubMed ID: 25525353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the effectiveness of the COPD Assessment Test (CAT) to evaluate COPD severity and exacerbation rates.
    Varol Y; Ozacar R; Balci G; Usta L; Taymaz Z
    COPD; 2014 Apr; 11(2):221-5. PubMed ID: 24111793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CAT (COPD Assessment Test) questionnaire as a predictor of the evolution of severe COPD exacerbations.
    García-Sidro P; Naval E; Martinez Rivera C; Bonnin-Vilaplana M; Garcia-Rivero JL; Herrejón A; Malo de Molina R; Marcos PJ; Mayoralas-Alises S; Ros JA; Valle M; Esquinas C; Barrecheguren M; Miravitlles M
    Respir Med; 2015 Dec; 109(12):1546-52. PubMed ID: 26542727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.
    Martinez CH; Murray S; Barr RG; Bleecker E; Bowler RP; Christenson SA; Comellas AP; Cooper CB; Couper D; Criner GJ; Curtis JL; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Kleerup E; Krishnan JA; Lazarus SC; Leidy NK; O'Neal W; Martinez FJ; Paine R; Rennard SI; Tashkin DP; Woodruff PG; Han MK;
    Ann Am Thorac Soc; 2017 May; 14(5):636-642. PubMed ID: 28459622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life measured by the St George's Respiratory Questionnaire and spirometry.
    Weatherall M; Marsh S; Shirtcliffe P; Williams M; Travers J; Beasley R
    Eur Respir J; 2009 May; 33(5):1025-30. PubMed ID: 19164350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study to monitor changes in spirometry and lung volume, following an exacerbation of Chronic Obstructive Pulmonary Disease (COPD), as part of a supported discharge program.
    Cushen B; McCormack N; Hennigan K; Sulaiman I; Costello RW; Deering B
    Respir Med; 2016 Oct; 119():55-62. PubMed ID: 27692148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD.
    Casanova C; Marin JM; Martinez-Gonzalez C; de Lucas-Ramos P; Mir-Viladrich I; Cosio B; Peces-Barba G; Solanes-García I; Agüero R; Feu-Collado N; Calle-Rubio M; Alfageme I; de Diego-Damia A; Irigaray R; Marín M; Balcells E; Llunell A; Galdiz JB; Golpe R; Lacarcel C; Cabrera C; Marin A; Soriano JB; Lopez-Campos JL; Soler-Cataluña JJ; de-Torres JP;
    Chest; 2015 Jul; 148(1):159-168. PubMed ID: 25612228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the COPD severity score for use in primary care: the NEREA study.
    Miravitlles M; Llor C; de Castellar R; Izquierdo I; Baró E; Donado E
    Eur Respir J; 2009 Mar; 33(3):519-27. PubMed ID: 19164354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD.
    Oki Y; Kaneko M; Fujimoto Y; Sakai H; Misu S; Mitani Y; Yamaguchi T; Yasuda H; Ishikawa A
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2869-2875. PubMed ID: 27920514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic obstructive pulmonary disease assessment test: usefulness for monitoring recovery and predicting poor course of disease after exacerbations.
    Pulido Herrero E; García Gutiérrez S; Antón Ladislao A; Piñera Salmerón P; Martín Corral MJ; Gorordo Unzueta MI; Lopetegui Eraso P; García Lamberechts EJ; Quintana López JM
    Emergencias; 2019 Feb; 31(1):21-26. PubMed ID: 30656869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depressive status explains a significant amount of the variance in COPD assessment test (CAT) scores.
    Miravitlles M; Molina J; Quintano JA; Campuzano A; Pérez J; Roncero C;
    Int J Chron Obstruct Pulmon Dis; 2018; 13():823-831. PubMed ID: 29563782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of short term re-exacerbation in patients with acute exacerbation of chronic obstructive pulmonary disease.
    Liu D; Peng SH; Zhang J; Bai SH; Liu HX; Qu JM
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1265-73. PubMed ID: 26170655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classification.
    Price DB; Baker CL; Zou KH; Higgins VS; Bailey JT; Pike JS
    Int J Chron Obstruct Pulmon Dis; 2014; 9():551-61. PubMed ID: 24920893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.